Key result
Malignancy comprises ~70% of primary retroperitoneal soft tissue tumors, requiring precise classification for targeted therapies.
Why the study?
Sarcomas are heterogeneous tumors with overlapping microscopic features posing diagnostic challenges, where correct classification is vital for prognostication and evolving targeted therapies.
Correct tumor classification of retroperitoneal soft tissue sarcomas is crucial for prognostication and guiding evolving targeted therapies.
Supports precise histopathology review for retroperitoneal masses; leaves open standardization of classification algorithms.
Retroperitoneal tumors are extremely rare. More than 70% of primary retroperitoneal soft tissue tumors are malignant. The most common sarcomas in the retroperitoneum include liposarcomas and leiomyosarcoma, however other sarcomas, along with benign mesenchymal tumors, can occur. Sarcomas are a heterogenous group of tumors with overlapping microscopic features, posing a diagnostic challenge for the pathologist. Correct tumor classification has become important for prognostication and the evolving targeted therapies for sarcoma subtypes. In this review, the pathology of retroperitoneal soft tissue sarcomas is discussed, which is important to the surgical oncologist. In addition, less common sarcomas and benign mesenchymal tumors of the retroperitoneum, which may mimic sarcoma clinically and pathologically, are also discussed.
No takes yet. Share an insight, caveat, or question.
Mack et al. (2022) conducted a review in Retroperitoneal Soft Tissue Sarcoma. More than 70% of primary retroperitoneal soft tissue tumors are malignant, making correct tumor classification essential for prognostication and targeted therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: